Bladder cancer cells may upregulate enzymes like tryptophan 2,3-dioxygenase (TDO) or indoleamine 2,3-dioxygenase (IDO), leading to heightened tryptophan degradation. The gene discussed is IDO2; the disease is urinary bladder carcinoma.